ad

3 Auto Components Maker, Footwear Retailer and Diagnostics Centres Operator Stocks With a Strong Future Roadmap: Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre

Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre: ROE of 13.9% to 19.8% and FY22 to FY26 revenue CAGR of 15.1% to 20.6%. Prices as of 13 Nov 2026.


16 Nov 2026 • 2:29 pm

3 Auto Components Maker, Footwear Retailer and Diagnostics Centres Operator Stocks With a Strong Future Roadmap: Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre

Quick Answer

The three auto part, footwear retail and lab stocks to watch are Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre. Their return on equity ranges from 13.9% to 19.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 15.1% to 20.6%. Metro Brands leads on both return on equity at 19.8% and revenue growth at 20.6% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.

Auto part, footwear retail and lab stocks give investors a way to track businesses that sit close to everyday demand in India. Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre cover an auto components maker, a footwear retailer and a diagnostics centres operator.

This list covers three auto part, footwear retail and lab stocks with complete current figures: Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Auto Part, Footwear Retail and Lab Stocks?

Auto part, footwear retail and lab stocks are listed companies that make suspension, braking and aluminium parts for two wheelers and cars, run large stores for branded footwear, and run diagnostic labs and imaging centres. Their earnings depend on vehicle output, retail demand and test volumes.

Auto Part, Footwear Retail and Lab Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Endurance Technologies 2,540.2 33,317 34.4 36.9 13.9 0.19
Metro Brands 838.15 23,316 55.4 37.0 19.8 0.76
Vijaya Diagnostic Centre 1,410.1 14,066 75.0 59.6 18.1 0.44

On valuation, Endurance Technologies trades at a P/E below the industry P/E, while Metro Brands and Vijaya Diagnostic Centre trade above it, which reflects the growth the market already expects. Readers comparing auto part, footwear retail and lab stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Auto Part, Footwear Retail and Lab Stocks Have a Strong Roadmap in India?

Auto part, footwear retail and lab stocks have a strong roadmap in India because rising vehicle technology content, strong appetite for branded footwear and wider use of preventive tests keep widening the market for these companies.

  • Auto components. Vehicles need dependable parts.
  • Footwear retail. Shoppers upgrade to branded footwear.
  • Diagnostics. Families test more for preventive care.

Why Endurance Technologies Features Among These Auto Part, Footwear Retail and Lab Stocks

Among the auto part, footwear retail and lab stocks on this list, Endurance Technologies is a Chhatrapati Sambhajinagar-based auto component maker that supplies suspension, brake systems, aluminium castings and transmission parts to two-wheeler, three-wheeler and car makers in India and Europe.

The company has a return on equity of 13.9%, a debt to equity ratio of 0.19 and a market capitalisation of Rs 33,317 crore. The stock trades at a P/E of 34.4, below the industry P/E of 36.9.

Revenue rose from Rs 7,590 crore in FY22 to Rs 14,720 crore in FY26, a compound annual growth rate of 18.0%. Net profit grew from Rs 461 crore in FY22 to Rs 952 crore in FY26, which works out to a compound annual growth rate of 19.9%. In the June 2026 quarter, revenue grew 29.6% year on year to Rs 4,348 crore, while net profit rose 8.0% to Rs 245 crore.

Roadmap: The company benefits from rising two-wheeler demand and from the move to anti-lock braking and premium suspension. Its European operations and growing business in electric vehicles widen its base.

What to watch: Track growth in braking and suspension content and the European business.

Why Metro Brands Features Among These Auto Part, Footwear Retail and Lab Stocks

Among the chassis maker, shoe chain and diagnostic centre shares on this list, Metro Brands is a Mumbai-based footwear retailer operating the Metro, Mochi, Walkway and Crocs outlets, and also selling through online channels and select partner brands.

Revenue rose from Rs 1,402 crore in FY22 to Rs 2,968 crore in FY26, a compound annual growth rate of 20.6%. Net profit grew from Rs 213 crore in FY22 to Rs 416 crore in FY26, which works out to a compound annual growth rate of 18.2%.

The company has a return on equity of 19.8%, a debt to equity ratio of 0.76 and a market capitalisation of Rs 23,316 crore. The stock trades at a P/E of 55.4, above the industry P/E of 37.0.

Roadmap: The company is opening new stores across cities and adding premium and international brands to its range. An omni-channel presence helps it reach a wider set of shoppers.

What to watch: Track store openings, premium brand share and online sales.

Why Vijaya Diagnostic Centre Features Among These Auto Part, Footwear Retail and Lab Stocks

Among the three companies on this list, Vijaya Diagnostic Centre is a Hyderabad-headquartered diagnostics chain that offers pathology and radiology services through a network of centres, with Hyderabad and Telangana as its home base.

In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%.

Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P/E of 75.0, above the industry P/E of 59.6.

Roadmap: The plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.

What to watch: Check the revenue contribution from newer regions and the pace at which new centres turn profitable.

Endurance Technologies vs Metro Brands vs Vijaya Diagnostic Centre on Key Financials

The table below sets the three auto part, footwear retail and lab stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Endurance Technologies 7,590 14,720 18.0% 952 6.5%
Metro Brands 1,402 2,968 20.6% 416 14.0%
Vijaya Diagnostic Centre 475 835 15.1% 173 20.7%

Metro Brands posts the highest return on equity in this group at 19.8%. Endurance Technologies has the largest FY26 revenue at Rs 14,720 crore, and Metro Brands shows the fastest revenue growth with a 20.6% compound annual rate. A useful habit with auto part, footwear retail and lab stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Auto Part, Footwear Retail and Lab Stocks

Every theme carries risks that deserve a check before any decision. For these auto part, footwear retail and lab stocks, the main points are: Long-term chassis maker, shoe chain and diagnostic centre shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Production cycles. Vehicle output can vary with demand.
  • Footfall and spending. Store sales follow consumer mood and seasons.
  • Capacity ramp up. New hospitals take time to fill beds and reach full returns.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter auto part, footwear retail and lab stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Auto Part, Footwear Retail and Lab Stocks

Auto part, footwear retail and lab stocks work best when investors track growth, valuation and return on equity side by side. Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre each have a clear plan to grow. Based on the 13 November 2026 close, Endurance Technologies trades at Rs 2,540.2, Metro Brands at Rs 838.15 and Vijaya Diagnostic Centre at Rs 1,410.1. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these auto part, footwear retail and lab stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track auto part, footwear retail and lab stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are auto part, footwear retail and lab stocks?

Ans. Auto part, footwear retail and lab stocks are listed companies that make suspension, braking and aluminium parts for two wheelers and cars, run large stores for branded footwear, and run diagnostic labs and imaging centres. Their earnings depend on vehicle output, retail demand and test volumes. This list looks at three of them, Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.

Which auto part, footwear retail and lab stocks are covered in this list?

Ans. This list covers Endurance Technologies, Metro Brands and Vijaya Diagnostic Centre. Based on the 13 November 2026 close, Endurance Technologies traded at Rs 2,540.2, Metro Brands at Rs 838.15 and Vijaya Diagnostic Centre at Rs 1,410.1. Their return on equity ranges from 13.9% to 19.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 15.1% to 20.6%.

Why do auto part, footwear retail and lab stocks have a strong future roadmap in India?

Ans. Auto part, footwear retail and lab stocks have a strong roadmap in India because rising vehicle technology content, strong appetite for branded footwear and wider use of preventive tests keep widening the market for these companies. The main drivers are as follows. Auto components. Vehicles need dependable parts. Footwear retail. Shoppers upgrade to branded footwear. Diagnostics. Families test more for preventive care. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Endurance Technologies performed financially?

Ans. Revenue rose from Rs 7,590 crore in FY22 to Rs 14,720 crore in FY26, a compound annual growth rate of 18.0%. Net profit grew from Rs 461 crore in FY22 to Rs 952 crore in FY26, which works out to a compound annual growth rate of 19.9%. In the June 2026 quarter, revenue grew 29.6% year on year to Rs 4,348 crore, while net profit rose 8.0% to Rs 245 crore. The company has a return on equity of 13.9%, a debt to equity ratio of 0.19 and a market capitalisation of Rs 33,317 crore. The stock trades at a P/E of 34.4, below the industry P/E of 36.9. Looking ahead, the company benefits from rising two-wheeler demand and from the move to anti-lock braking and premium suspension. Its European operations and growing business in electric vehicles widen its base.

How has Metro Brands performed financially?

Ans. Revenue rose from Rs 1,402 crore in FY22 to Rs 2,968 crore in FY26, a compound annual growth rate of 20.6%. Net profit grew from Rs 213 crore in FY22 to Rs 416 crore in FY26, which works out to a compound annual growth rate of 18.2%. The company has a return on equity of 19.8%, a debt to equity ratio of 0.76 and a market capitalisation of Rs 23,316 crore. The stock trades at a P/E of 55.4, above the industry P/E of 37.0. Looking ahead, the company is opening new stores across cities and adding premium and international brands to its range. An omni-channel presence helps it reach a wider set of shoppers.

How has Vijaya Diagnostic Centre performed financially?

Ans. Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P/E of 75.0, above the industry P/E of 59.6. Looking ahead, the plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.

What risks should investors check before buying auto part, footwear retail and lab stocks?

Ans. Investors should check a few risks before buying auto part, footwear retail and lab stocks. Production cycles. Vehicle output can vary with demand. Footfall and spending. Store sales follow consumer mood and seasons. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of auto part, footwear retail and lab stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down